Table 4.
Cohort I | Ductal | Lobular | Medullary | Mucinous | |||
---|---|---|---|---|---|---|---|
PKCα intensity | 0 | 25 | 3 | 0 | 2 | ||
p* = 0.295 | 1 | 20 | 0 | 1 | 0 | ||
2 | 4 | 0 | 0 | 0 | |||
3 | 4 | 0 | 1 | 0 | |||
n.e. | 42 | 3 | 0 | 2 | |||
PKCδ intensity | 0 | 12 | 0 | 0 | 1 | ||
p* = 0.850 | 1 | 33 | 1 | 2 | 1 | ||
2 | 7 | 0 | 0 | 0 | |||
3 | 0 | 0 | 0 | 0 | |||
n.e. | 43 | 5 | 0 | 2 | |||
PKCε intensity | 0 | 0 | 0 | 0 | 0 | ||
p* = 0.800 | 1 | 12 | 0 | 1 | 0 | ||
2 | 29 | 1 | 1 | 2 | |||
3 | 9 | 0 | 0 | 0 | |||
n.e. | 45 | 5 | 0 | 2 | |||
Cohort II | Ductal | Lobular | Medullary | Mucinous | Tubular | Mixed | |
PKCα intensity | 0 | 124 | 17 | 1 | 10 | 14 | 13 |
p*<0.001 | 1 | 34 | 4 | 5 | 2 | 3 | 3 |
2 | 10 | 0 | 4 | 0 | 0 | 1 | |
3 | 3 | 0 | 2 | 0 | 0 | 0 | |
n.e. | 168 | 52 | 3 | 5 | 17 | 17 | |
PKCε intensity | 0 | 2 | 1 | 0 | 0 | 0 | 0 |
p* = 0.328 | 1 | 38 | 9 | 7 | 4 | 5 | 5 |
2 | 90 | 19 | 4 | 7 | 9 | 7 | |
3 | 41 | 5 | 1 | 1 | 1 | 7 | |
n.e. | 168 | 39 | 3 | 5 | 19 | 15 |
*χ2-test, p < 0.05 in bold, n.e. = not evaluated